Literature DB >> 24749660

Uricaemia and ejection fraction in elderly heart failure outpatients.

Claudio Borghi1, Eugenio R Cosentino, Elisa R Rinaldi, Arrigo F G Cicero.   

Abstract

BACKGROUND: Preliminary data suggest that serum uric acid (SUA) could be involved in the prognosis of chronic heart failure (HF). The aim of our study was to test the relationship between SUA and left ventricular ejection fraction (EF%) in a cohort of elderly hypertensive outpatients with chronic HF.
DESIGN: We consecutively enrolled 487 elderly outpatients (M = 59·8%; F = 40·2%; mean age: 72 ± 11 years old) affected by mild-to-moderate hypertensive and/or ischaemic HF, evaluating the relationship between SUA and EF%.
RESULTS: In an univariate analysis, SUA was inversely related with EF%: B = -4·392, 95% CI -5·427 to -3·357, P < 0·001. After adjustment for a large number of variables in a multivariate analysis, the value of EF% was best predicted by SUA (B = -3·005, 95% CI -4·386 to -1·623, P < 0·001), log brain natriuretic peptide (BNP: B = -2·341, 95% CI -3·137 to -1·248, P < 0·001) and mean arterial pressure (MAP: B = 0·241, 95% CI 0·047 to 0·435, P = 0·015). A separate analysis by estimated glomerular filtration rate (eGFR) levels confirmed the inverse relationship between SUA and EF% in patients with normal renal function. A separate analysis by sex confirmed that SUA and log BNP were significant strong predictors of EF% in men, but not in women where the best predictors were log BNP, MAP and body mass index. The predicting role of SUA was apparently independent of eGFR and use of diuretics.
CONCLUSION: Serum uric acid seems to be inversely related to EF% in male elderly patients with HF after adjustment for the several confounding factors. This observation supports a primary negative effect of SUA on left ventricular function that warrants further investigations.
© 2014 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Ejection fraction; elderly; heart failure; outpatients; serum uric acid

Mesh:

Substances:

Year:  2014        PMID: 24749660     DOI: 10.1111/eci.12273

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

Review 1.  Uric Acid and Cardiovascular Disease: An Update.

Authors:  Maria Lorenza Muiesan; Claudia Agabiti-Rosei; Anna Paini; Massimo Salvetti
Journal:  Eur Cardiol       Date:  2016-08

Review 2.  Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.

Authors:  Claudio Borghi; Alberto Palazzuoli; Matteo Landolfo; Eugenio Cosentino
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

3.  Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients.

Authors:  Arrigo Francesco Giuseppe Cicero; Eugenio Roberto Cosentino; Masanari Kuwabara; Daniela Degli Esposti; Claudio Borghi
Journal:  Intern Emerg Med       Date:  2019-03-12       Impact factor: 3.397

4.  Oxidative stress markers and C-reactive protein are related to severity of heart failure in patients with dilated cardiomyopathy.

Authors:  Celina Wojciechowska; Ewa Romuk; Andrzej Tomasik; Bronisława Skrzep-Poloczek; Ewa Nowalany-Kozielska; Ewa Birkner; Wojciech Jacheć
Journal:  Mediators Inflamm       Date:  2014-10-23       Impact factor: 4.711

5.  Hyperuricemia Is Associated with Left Ventricular Dysfunction and Inappropriate Left Ventricular Mass in Chronic Kidney Disease.

Authors:  Tai-Hua Chiu; Pei-Yu Wu; Jiun-Chi Huang; Ho-Ming Su; Szu-Chia Chen; Jer-Ming Chang; Hung-Chun Chen
Journal:  Diagnostics (Basel)       Date:  2020-07-24

6.  Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial.

Authors:  Satoshi Suzuki; Akiomi Yoshihisa; Tetsuro Yokokawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Akihiro Tsuda; Tatsunori Tsuda; Toshiyuki Ishibashi; Ichiro Konno; Osamu Yamaguchi; Hirofumi Machii; Naoki Nozaki; Takeshi Niizeki; Takuya Miyamoto; Yasuchika Takeishi
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

Review 7.  Hyperuricemia and the Risk of Heart Failure: Pathophysiology and Therapeutic Implications.

Authors:  Ke Si; Chijing Wei; Lili Xu; Yue Zhou; Wenshan Lv; Bingzi Dong; Zhongchao Wang; Yajing Huang; Yangang Wang; Ying Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-12       Impact factor: 5.555

8.  Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus.

Authors:  Matthew W Segar; Ahmed A Kolkailah; Robert Frederich; Annpey Pong; Christopher P Cannon; Francesco Cosentino; Samuel Dagogo-Jack; Darren K McGuire; Richard E Pratley; Chih-Chin Liu; Mario Maldonado; Jie Liu; Nilo B Cater; Ambarish Pandey; David Z I Cherney
Journal:  Diabetes Obes Metab       Date:  2022-06-15       Impact factor: 6.408

9.  The relationship between serum uric acid and cognitive function in patients with chronic heart failure.

Authors:  Weihua Niu; Huifeng Yang; Chengzhi Lu
Journal:  BMC Cardiovasc Disord       Date:  2020-08-20       Impact factor: 2.298

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.